Hydrogen: A Potential New Adjuvant Therapy for COVID-19 Patients
Fuxun Yang, Ruiming Yue, Xiaoxiu Luo, Rongan Liu, Xiaobo Huang
Abstract
Hydrogen has been shown to have antioxidant, anti-inflammatory, hormone-regulating, and apoptosis-resistance properties, among others. Based on a review of the research, the use of hydrogen might reduce the destructive cytokine storm and lung injury caused by SARS-CoV-2 during COVID-19 (Corona Virus Disease 2019) in the early stage, stimulating ropy sputum drainage, and ultimately reducing the incidence of severe disease. Molecular hydrogen treatment has the potential to become a new adjuvant therapy for COVID-19, but its efficacy and safety require large clinical trials and further confirmation.
Topics & Concepts
MedicineCytokine stormCoronavirus disease 2019 (COVID-19)DiseaseAdjuvantSputumImmunologyIntensive care medicineBioinformaticsInternal medicinePathologyInfectious disease (medical specialty)BiologyTuberculosisHydrogen's biological and therapeutic effectsMedical and Biological Ozone Research